In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor

被引：0
|
作者：
Burrell, LM
Rockell, MD
Powell, J
Johnston, CI
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1999年 / 12卷 / 04期
关键词：
vasopeptidase inhibitors; omapatrilat; angiotensin; natriuretic peptides;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：119A / 119A
页数：1
相关论文
共 50 条
  • [1] Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo
    Bäcklund, T
    Palojoki, E
    Grönholm, T
    Eriksson, A
    Vuolteenaho, O
    Laine, M
    Tikkanen, I
    PHARMACOLOGICAL RESEARCH, 2001, 44 (05) : 411 - 418
  • [2] Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus
    Tikkanen, T
    Tikkanen, I
    Rockell, MD
    Allen, TJ
    Johnston, CI
    Cooper, ME
    Burrell, LM
    HYPERTENSION, 1998, 32 (04) : 778 - 785
  • [3] CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme
    Battistini, Bruno
    Daull, Philippe
    Jeng, Arco Y.
    CARDIOVASCULAR DRUG REVIEWS, 2005, 23 (04): : 317 - 330
  • [4] Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome
    Eizenberg, Yoav
    Grossman, Ehud
    Peleg, Edna
    Shabtai, Zehava
    Sharabi, Yehonatan
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (04) : 227 - 231
  • [5] Renal hemodynamic and natriuretic effects of concomitant angiotensin-converting enzyme and neutral endopeptidase inhibition in men
    Regamey, F
    Maillard, M
    Nussberger, R
    Brunner, HR
    Burnier, M
    HYPERTENSION, 2002, 40 (03) : 266 - 272
  • [6] Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch, W
    Dominiak, P
    Dendorfer, A
    JOURNAL OF HYPERTENSION, 2005, 23 (08) : 1597 - 1604
  • [7] Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: Role of natriuretic peptides and angiotensin II
    Rademaker, MT
    Charles, CJ
    Espiner, EA
    Nicholls, MG
    Richards, AM
    Kosoglou, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (01) : 116 - 125
  • [8] Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats
    Pu, O
    Amiri, F
    Gannon, P
    Schiffrin, EL
    JOURNAL OF HYPERTENSION, 2005, 23 (02) : 401 - 409
  • [9] Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat
    Oliveri, C
    Ocaranza, MP
    Campos, X
    Lavandero, S
    Jalil, JE
    HYPERTENSION, 2001, 38 (03) : 650 - 654
  • [10] Role of angiotensin-converting enzyme and neutral endopeptidase in flow-dependent remodeling
    Korshunov, VA
    Massett, MP
    Carey, RM
    Berk, BC
    JOURNAL OF VASCULAR RESEARCH, 2004, 41 (02) : 148 - 156
12345